Remdesivir for the Treatment of COVID-19: An Updated Systematic Review and Meta-Analysis
View ORCID ProfileTodd C. Lee, View ORCID ProfileSrinivas Murthy, Olivier Del Corpo, Julien Senécal, View ORCID ProfileGuillaume Butler-Laporte, View ORCID ProfileZahra N Sohani, View ORCID ProfileJames M. Brophy, View ORCID ProfileEmily G. McDonald
doi: https://doi.org/10.1101/2022.01.22.22269545
Todd C. Lee
1Division of Infectious Diseases, Department of Medicine, McGill University, Montréal, Canada
2Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montréal, Canada
3Department of Epidemiology, Occupational Health, and Biostatistics, McGill University, Montréal, Canada
MD MPH FIDSASrinivas Murthy
4Department of Pediatrics, University of British Columbia, Vancouver, Canada
MDOlivier Del Corpo
5Faculty of Medicine and Health Sciences, McGill University, Montréal, Canada
MD MScJulien Senécal
5Faculty of Medicine and Health Sciences, McGill University, Montréal, Canada
BScGuillaume Butler-Laporte
3Department of Epidemiology, Occupational Health, and Biostatistics, McGill University, Montréal, Canada
MDZahra N Sohani
1Division of Infectious Diseases, Department of Medicine, McGill University, Montréal, Canada
MD PhDJames M. Brophy
3Department of Epidemiology, Occupational Health, and Biostatistics, McGill University, Montréal, Canada
7Division of Cardiology, Department of Medicine, McGill University, Montréal, Canada
MD PhDEmily G. McDonald
2Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montréal, Canada
6Division of General Internal Medicine, Department of Medicine, McGill University, Montréal, Canada
MD MScData Availability
All data produced in the present work are contained in the manuscript.
Posted January 23, 2022.
Remdesivir for the Treatment of COVID-19: An Updated Systematic Review and Meta-Analysis
Todd C. Lee, Srinivas Murthy, Olivier Del Corpo, Julien Senécal, Guillaume Butler-Laporte, Zahra N Sohani, James M. Brophy, Emily G. McDonald
medRxiv 2022.01.22.22269545; doi: https://doi.org/10.1101/2022.01.22.22269545
Remdesivir for the Treatment of COVID-19: An Updated Systematic Review and Meta-Analysis
Todd C. Lee, Srinivas Murthy, Olivier Del Corpo, Julien Senécal, Guillaume Butler-Laporte, Zahra N Sohani, James M. Brophy, Emily G. McDonald
medRxiv 2022.01.22.22269545; doi: https://doi.org/10.1101/2022.01.22.22269545
Subject Area
Subject Areas
- Addiction Medicine (401)
- Allergy and Immunology (711)
- Anesthesia (204)
- Cardiovascular Medicine (2963)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12774)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4605)
- Geriatric Medicine (422)
- Health Economics (731)
- Health Informatics (2938)
- Health Policy (1070)
- Hematology (390)
- HIV/AIDS (927)
- Medical Education (429)
- Medical Ethics (116)
- Nephrology (473)
- Neurology (4385)
- Nursing (237)
- Nutrition (642)
- Oncology (2282)
- Ophthalmology (649)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (499)
- Public and Global Health (6971)
- Radiology and Imaging (1538)
- Respiratory Medicine (917)
- Rheumatology (442)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)